INKT Insider Trading Activity and SEC Form 4 Filings
INKT insider trading summary
Over the past 12 months, insiders at MiNK Therapeutics, Inc. (INKT) reported 7 sales worth $101K by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $101K.
Latest INKT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 12, 2026 | Jennifer Buell | Chief Executive Officer | Sell | $73K (6,938 @ $10.56) |
| Mar 10, 2026 | Barbara Ryan | Insider | Sell | $5K (300 @ $15.28) |
| Mar 10, 2026 | Barbara Ryan | Insider | Sell | $8K (500 @ $15.57) |
| Mar 10, 2026 | Barbara Ryan | Insider | Sell | $8K (500 @ $15.30) |
| Mar 9, 2026 | Barbara Ryan | Insider | Sell | $2K (200 @ $10.17) |
| Mar 2, 2026 | Barbara Ryan | Insider | Sell | $1K (100 @ $10.83) |
| Feb 27, 2026 | Barbara Ryan | Insider | Sell | $4K (400 @ $10.86) |
| Oct 16, 2023 | Agenus Inc | Insider | Buy | $472 (429 @ $1.10) |
| Oct 13, 2023 | Agenus Inc | Insider | Buy | $21K (19,373 @ $1.10) |
| Oct 12, 2023 | Agenus Inc | Insider | Buy | $3K (3,173 @ $1.10) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.